Background: High-risk human papillomavirus (hrHPV)-based cervical cancer screening in
the Netherlands led to a substantial increase in number of colposcopy referrals and low …

Background: High-risk human papillomavirus (hrHPV) testing is utilized in primary cervical
cancer screening, generally along with cytology, to triage abnormalities to colposcopy. Most …

Objective To establish the prevalence of high‐grade cervical intraepithelial neoplasia
(CIN2+) in women referred to colposcopy with persistent high‐risk human papillomavirus …

Cervical cancer was designated a global health priority by the World Health Organization in
2018. Though preventable, cervical cancer is expected to affect 700,000 women and claim …

Background: Recommendations for high-risk human papillomavirus (HR-HPV) testing as an
adjunct to cytology for cervical cancer screening differ by age group, because HR-HPV tests …

Background: High-risk human papillomavirus (HR-HPV) testing has become a preferred
cervical cancer screening strategy in some countries due to its superior sensitivity over …

High‐risk human papillomavirus (hrHPV) testing has a higher sensitivity but lower specificity
than cytology for detection of high‐grade intraepithelial neoplasia (CIN). To avoid over …

HPV testing is more sensitive than cytology for cervical screening. However, to incorporate
HPV tests into screening, risk‐stratification (“triage”) of HPV‐positive women is needed to …

Introduction Human papillomavirus (HPV) testing as the primary cervical cancer screening
method is implemented in several countries. We report data from the first round of a large …

Background: Primary high-risk human papillomavirus (hr-HPV) testing of self-collected
cervico-vaginal swabs could increase cervical cancer screening coverage, although triage …